TheraRadar
← Back
Data updated: Mar 29, 2026

OHM LABS

OncologyInfectious DiseaseGastroenterology
Generics

OHM LABS is a generic drug manufacturer focused on Oncology, Infectious Disease, Gastroenterology.

1985
Since
10
Drugs
-
Trials
82
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

LOPERAMIDE HYDROCHLORIDE 2025-12-29
ACETAMINOPHEN 2025-12-05
LOPERAMIDE HYDROCHLORIDE 2025-11-17
SODIUM OXYBATE 2025-11-05
LOPERAMIDE HYDROCHLORIDE 2025-09-19
SODIUM OXYBATE 2025-09-10
SODIUM OXYBATE 2025-07-08
REMS
VALSARTAN 2025-06-05
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 60%
0 drugs Phase 3: 146 Phase 2: 73 Phase 1: 97
Infectious Disease 26%
0 drugs Phase 3: 63 Phase 2: 34 Phase 1: 38
Gastroenterology 5%
0 drugs Phase 3: 10 Phase 2: 7 Phase 1: 16
Cardiovascular 4%
0 drugs Phase 3: 9 Phase 2: 9 Phase 1: 7
Immunology 4%
0 drugs Phase 3: 7 Phase 2: 9 Phase 1: 14

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Immunology, Gastroenterology
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Immunology
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Cardiovascular
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Infectious Disease
COSETTE other
Cardiovascular, Infectious Disease, Immunology, Oncology